Cardiac glycoside
Cardiac glycosides are a class of organic compounds that increase the output force of the heart and decrease its rate of contractions by inhibiting the cellular sodium-potassium ATPase pump. Their beneficial medical uses are as treatments for congestive heart failure and cardiac arrhythmias; however, their relative toxicity prevents them from being widely used. Most commonly found as secondary metabolites in several plants such as foxglove plants, these compounds nevertheless have a diverse range of biochemical effects regarding cardiac cell function and have also been suggested for use in cancer treatment.
Cardiac glycoside | |
---|---|
Drug class | |
The general structure of a cardiac glycoside molecule. | |
Class identifiers | |
Use | Congestive heart failure |
ATC code | C01A |
Biological target | Na+ /K+ -ATPase |
External links | |
MeSH | D002301 |
Legal status | |
In Wikidata |
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.